The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what they hope the Trump administration doesn’t change.
FDA approves Johnson & Johnson’s nasal spray for depression
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) active Investigational New Drug (IND) applications. These INDs include the EBVALLO (tabelecleucel) program for patients two years of age and older with Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD),
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,
Red No. 3, also known as erythrosine, is a color additive made from petroleum that gives foods and drinks a bright, cherry-red color.
The Food and Drug Administration said it is banning the use of Red No. 3, which is founds in over 3,000 products. Here's a list of a few items
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .
The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place nutrition labels on the front of their products instead of the back.
More than a dozen cats have been killed or sickened by bird flu that is spreading in raw food products, the Food and Drug Administration says, prompting a federal probe into how the virus got into the pet food supply chain.
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression,
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,